Clinical Trial Update: Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating ursodeoxycholic acid as treatment for polycystic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Autosomal Dominant
• Polycystic Liver Disease

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Polycystic Liver Disease, Polycystic Kidney, Autosomal Dominant | Phase 2 | Status: COMPLETED